Accueil » Communiqués de presse » Valbiotis announces positive results in the bioavailability and mode of action TOTUM•854 clinical study, against high blood pressure.
Les communiqués de presse
30Jan2023
Valbiotis announces positive results in the bioavailability and mode of action TOTUM•854 clinical study, against high blood pressure.
We use cookies to guarantee the best experience on our site, to make statistics, to offer you third party services such as video like Youtube, social networks sharing. By clicking on validate and closing this banner, you accept the deposit of cookies.AcceptRefuseMore information
You can revoke your consent at any time by using the "Revoke Consent" button.Revoke consent
